{"slideshow_credits": null, "snippet": "The revolt against unjustifiably high prices of cancer medications has been joined by more than 100 leukemia experts from more than 15 countries.", "abstract": "Editorial applauds revolt against unjustifiably high cancer drug prices by more than 100 leukemia experts from more than 15 countries; expresses hope that effort by leukemia experts will further reduce cancer drug prices.", "section_name": "Opinion", "print_page": "22", "document_type": "article", "byline": {"person": [], "organization": "THE EDITORIAL BOARD", "original": "By THE EDITORIAL BOARD", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/05/02/opinion/exorbitant-prices-for-cancer-drugs.html", "lead_paragraph": "The revolt against unjustifiably high prices of cancer medications has been joined by more than 100 leukemia experts from more than 15 countries.", "headline": {"seo": "Exorbitant Prices for Cancer Drugs", "main": "Exorbitant Prices for Leukemia Drugs", "print_headline": "Exorbitant Prices for Leukemia Drugs", "content_kicker": "Editorial", "kicker": "Editorial"}, "_id": "5181bda6cf28d05efe0001ab", "word_count": "332", "multimedia": [], "pub_date": "2013-05-02T00:00:00Z", "source": "The New York Times", "news_desk": "Editorial", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Cancer", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Leukemia", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Memorial Sloan-Kettering Cancer Center", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Editorials", "name": "subject", "is_major": "Y", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "Editorial"}